Sort   by:  
 Page size 
ProteomicsKK-LC-1 as a feasible therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer
Failure to achieve complete elimination of triple negative breast cancer (TNBC) stem cells after adjuvant therapy is associated with poor outcomes. Aldehyde dehydrogenase 1 (ALDH1) is a marker of breast cancer stem cells (BCSCs), and its enzymatic activity regulates tumor stemness. Identifying upstr...
ORGANISM(S): Homo sapiens (Human) 
2023-04-12 | PXD040200 | Pride
Cancer stem cell Tnbc Hippo signaling pathway Aldh+ stemness Protein-protein inhibitor. 
Sort   by:  
 Page size